The Diabetes and Endocrinology Research Team delivers high quality clinical trials and research aimed at improving the care, treatment and long-term outcomes of people living with diabetes and endocrine conditions.

We support the safe and ethical delivery of a wide range of trials, collaborating closely with patients, clinicians, and academic partners.

Our team is committed to patient-centered research, ensuring participants are well supported with contributing to evidence that helps shape future diabetes and endocrine care.

Current ongoing studies include:

• PROTECT – Pregnancy outcomes using continuous glucose monitoring technology in pregnant women with early-onset Type 2 diabetes.
• ADDRESS-2 – An incident and high risk type 1 diabetes research study – An after diagnosis of diabetes, research support system.
• Hyper-Aid – Hydrocortisone versus Prednisolone for Treatment of Adrenal Insufficiency Disease.

Recently closed studies:

• MYDIABETES – A cross-sectional study to characterise young-onset diabetes in two UK ethnics groups.
• Abbott – Frequency of Ketosis in People Living with Diabetes or Other Medical Conditions.
• Sensors for Healthcare – a socio-technical assessment of glucose monitoring in Bradford.